甘诺斯特A,一种来自药用真菌Ganoderma lingzhi的类固醇
Jia-Hui Du1, Xuan Zhao1, Fei Zhang1
1School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Journal of Asian natural products research
|April 12, 2024
概括
研究人员发现了一种新的诺类固醇,ganonorsterone A,来自药用真菌Ganoderma lingzhi. 这种化合物对免疫细胞中氧化 (NO) 生产有中度的抑制作用.
科学领域:
- 自然产品化学 自然产品化学
- 药用菌类学 药用菌类学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药用真菌Ganoderma lingzhi是一种生物活性化合物的来源.
- 类固醇和类固醇是具有不同生物活性的自然产品类别.
研究的目的:
- 为了隔离和表征新型化合物从Ganoderma lingzhi果实体.
- 评估分离化合物的生物活性,特别是它们对氧化生产的影响.
主要方法:
- 植物化学研究涉及隔离技术.
- 使用质谱 (MS) 和核磁共振 (NMR) 数据阐明结构.
- 通过量子化学计算确定绝对配置,包括电子循环二元化 (ECD) 和13C NMR-DP4+分析.
- 在RAW 264.7巨细胞中抑制氧化的生物试验.
主要成果:
- 隔离了一种新的诺斯类药物,加诺诺斯特A (1).
- 一个已知的类固醇的识别,亚二醇 (2).
- 甘诺斯特A证明了中度抑制氧化的产生.
结论:
- 甘诺斯特A是一种新型的诺斯特,从甘诺德玛lingzhi中分离出来.
- 结构和立体化学分配被严格确认.
- 甘诺斯特A通过NO抑制表现出潜在的抗炎性质.
更多相关视频
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K


